BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

351 related articles for article (PubMed ID: 16104238)

  • 1. [Pre and post-vaccinal rubella seroepidemiology in Brittany (1971-1975). Comparative study of Cendehill and Plotkin's strains].
    Zou J; Senecal J; Morvan A; Roussey A
    Ann Pediatr (Paris); 1976 Feb; 23(2):111-8. PubMed ID: 16104238
    [No Abstract]   [Full Text] [Related]  

  • 2. [Rubella vaccination program in Brittany (1971-1975)].
    Senecal J; Zourbas J; Morvan A; Roussey A
    Ann Pediatr (Paris); 1976 Feb; 23(2):105-9. PubMed ID: 16104237
    [No Abstract]   [Full Text] [Related]  

  • 3. Seroepidemiology study of rubella antibodies among pregnant women from seven Asian countries: evaluation of the rubella vaccination program in Taiwan.
    Tseng HF; Chang CK; Tan HF; Yang SE; Chang HW
    Vaccine; 2006 Jul; 24(29-30):5772-7. PubMed ID: 16759764
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Current lessons from 20th century serosurveillance data on rubella.
    Cooper LZ
    Clin Infect Dis; 2001 Oct; 33(8):1287. PubMed ID: 11565066
    [No Abstract]   [Full Text] [Related]  

  • 5. Age-specific rubella seroprevalence in unvaccinated adolescents in Ankara, Turkey.
    Yalcin A; Caliskan D; Isik A
    East Mediterr Health J; 2008; 14(5):1036-43. PubMed ID: 19161075
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reducing the global burden of congenital rubella syndrome: report of the World Health Organization Steering Committee On Research Related To Measles and Rubella Vaccines and Vaccination, June 2004.
    Best JM; Castillo-Solorzano C; Spika JS; Icenogle J; Glasser JW; Gay NJ; Andrus J; Arvin AM
    J Infect Dis; 2005 Dec; 192(11):1890-7. PubMed ID: 16267759
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Comparative studies of the immunogenic and reactogenic properties of various vaccines against rubella. I. Seroconversion and post-vaccination reactions in girls immunized against rubella with Almevax vaccine].
    KaƄtoch M; Rudnicka H; Imbs D
    Przegl Epidemiol; 1985; 39(3-4):301-8. PubMed ID: 3832164
    [No Abstract]   [Full Text] [Related]  

  • 8. [Seroprevalence of rubella among the young female healthcare personnel in the Mahdia Sfar teaching hospital, Tunisia].
    Ben Haj Khalifa A; Berriri S; Kheder M
    Med Mal Infect; 2011 Sep; 41(9):493-4. PubMed ID: 21764535
    [No Abstract]   [Full Text] [Related]  

  • 9. Seroepidemiology of rubella in northern Greece.
    Gioula G; Diza-Mataftsi E; Alexiou-Daniel S; Kyriazopoulou-Dalaina V
    Eur J Clin Microbiol Infect Dis; 2004 Aug; 23(8):631-3. PubMed ID: 15243817
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rubella serosurveys at three Aravind Eye Hospitals in Tamil Nadu, India.
    Vijayalakshmi P; Anuradha R; Prakash K; Narendran K; Ravindran M; Prajna L; Brown D; Robertson SE
    Bull World Health Organ; 2004 Apr; 82(4):259-64. PubMed ID: 15259254
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence of rubella antibodies among schoolgirls in Sana'a, Republic of Yemen.
    Sallam TA; Raja'a YA; Benbrake MS; Al-Shaibani KS; Al-Hababi AA
    East Mediterr Health J; 2003; 9(1-2):148-51. PubMed ID: 15562744
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence of HI antibody titer against rubella virus to determine the effect of mass vaccination in Tehran.
    Soleimanjahi H; Bamdad T; Fotouhi F; Roustai MH; Faghihzadeh S
    J Clin Virol; 2005 Oct; 34(2):153-4. PubMed ID: 16076562
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Seroepidemiology of rubella virus infection among female residents on the offshore islets of Taiwan.
    Lin DB; Chen CJ
    J Trop Med Hyg; 1994 Apr; 97(2):75-80. PubMed ID: 8170006
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of rubella seroepidemiological data for assessment of previous vaccination policy and for decision making in response to epidemics in Israel.
    Cohen D; Muhsen Kh; Aboudy Y; Harari H; Mendelson E; Green MS
    Vaccine; 2006 Jul; 24(27-28):5604-8. PubMed ID: 16716460
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Seroprevalence of rubella among Jordanian women of childbearing age.
    Jarour N; Hayajneh WA; Balbeesi A; Otoom H; Al-Shurman A; Kharabsheh S
    Vaccine; 2007 May; 25(18):3615-8. PubMed ID: 17280747
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Immune response of rubella vaccine in the populations with different age groups].
    Xiong XW; Diao LD; Yan XL
    Zhonghua Liu Xing Bing Xue Za Zhi; 1997 Aug; 18(4):227-9. PubMed ID: 9812525
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rubella susceptibility in sixth graders: effectiveness of current immunization practice.
    Lawless MR; Abramson JS; Harlan JE; Kelsey DS
    Pediatrics; 1980 Jun; 65(6):1086-9. PubMed ID: 7375231
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Evaluation of the specific immune response after anti-rubella vaccination].
    Cellesi C; Rossolini A; Rossolini GM; Bianchi Bandinelli ML; Cusi MG; Egisto Valensin P
    Quad Sclavo Diagn; 1988; 24(1-4):97-105. PubMed ID: 3268925
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rubella immunity levels in the United States population: has the threshold of viral elimination been reached?
    Hyde TB; Kruszon-Moran D; McQuillan GM; Cossen C; Forghani B; Reef SE
    Clin Infect Dis; 2006 Nov; 43 Suppl 3():S146-50. PubMed ID: 16998774
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Has the United States population been adequately vaccinated to achieve rubella elimination?
    Bloom S; Smith P; Stanwyck C; Stokley S
    Clin Infect Dis; 2006 Nov; 43 Suppl 3():S141-5. PubMed ID: 16998773
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.